Coated Endotracheal Tube Market Overview:
Coated Endotracheal Tube Market was valued at $1.7 billion in 2016, and is estimated to reach $2.6 billion by 2023, growth of at a CAGR of 6.5% during the forecast time period.
Endotracheal tube is a metallic or perhaps plastic-type tube that is introduced in the trachea via the mouth or nose to substantiate the efficient change of oxygen and even carbon dioxide and then in addition retain the patient’s airway. Coated endotracheal tube is a specialized tube coated with antithrombotic products which is used to prevent coagulation or perhaps antibiotic providers which include polyvinyl chloride, silver, and several drugs to limit the rate of growth of the bacteria on the surface of endotracheal tube. Endotracheal tube needs to be exchanged on a regular basis, subsequently; it causes unnecessary discomfort to the patients. To prevent frequent replacements, tubes are therefore, treated with antibacterial agents.
Coated Endotracheal Tube Market Size
Developing number of surgical treatments due to expanding chronic respiratory health conditions including cardiovascular conditions, respiratory illnesses, diabetes, cancer, and other lung injuries are the factors that contribute to the growth of the industry. Further, growing require for ventilator associated pneumonia and thus rate of growth in geriatric population that is highly prone to chronic diseases also importantly contribute to the market growth. However, post-operative complications associated with endotracheal intubation and additionally lack of skilled industry experts is the factors that restrict the market growth.